Sunshine Biopharma (SBFM) EBT Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFM) EBT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | -24.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.30% |
| Mar 31, 2026 | 9.10% |
| Dec 31, 2025 | 57.94% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | -54.31% |
| Mar 31, 2025 | 0.44% |
| Dec 31, 2024 | -75.74% |
| Sep 30, 2024 | 37.58% |
| Jun 30, 2024 | 33.73% |
| Mar 31, 2024 | 41.14% |
| Dec 31, 2023 | 1.69% |
| Sep 30, 2023 | 4.39% |
| Jun 30, 2023 | 3.54% |
| Mar 31, 2023 | -159.97% |
| Dec 31, 2022 | -288.62% |
| Sep 30, 2022 | -60.83% |
| Jun 30, 2022 | -60.32% |
| Mar 31, 2022 | -83.39% |
| Dec 31, 2021 | 59.08% |
| Sep 30, 2021 | -64.18% |